These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25993066)

  • 21. Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.
    Katsagoni CN; Papatheodoridis GV; Ioannidou P; Deutsch M; Alexopoulou A; Papadopoulos N; Papageorgiou MV; Fragopoulou E; Kontogianni MD
    Br J Nutr; 2018 Jul; 120(2):164-175. PubMed ID: 29947322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Value of serum osteoprotegerin in noninvasive diagnosis of nonalcoholic steatohepatitis].
    Yang M; Liu Y; Zhou G; Guo X; Zou S; Liu S; Jiang L; Liu Y; Zhu L; Guo C; Zhao J
    Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):96-101. PubMed ID: 26983475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up study.
    Lu ZY; Shao Z; Li YL; Wulasihan M; Chen XH
    World J Gastroenterol; 2016 Apr; 22(13):3663-9. PubMed ID: 27053858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sleep Duration and Media Time Have a Major Impact on Insulin Resistance and Metabolic Risk Factors in Obese Children and Adolescents.
    Sayin FK; Buyukinan M
    Child Obes; 2016 Aug; 12(4):272-8. PubMed ID: 26978730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of alanine aminotransferase concentration with cardiometabolic risk factors in children and adolescents: the CASPIAN-V cross-sectional study.
    Kelishadi R; Qorbani M; Heshmat R; Motamed-Gorji N; Motlagh ME; Ziaodini H; Taheri M; Shafiee G; Aminaee T; Ahadi Z; Heidari-Beni M
    Sao Paulo Med J; 2018; 136(6):511-519. PubMed ID: 30892481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The ZJU index: a useful indicator for recognizing insulin resistance in the Chinese general population.
    Ji B; Qu H; Wang H; Wei H; Deng H
    Acta Diabetol; 2016 Oct; 53(5):817-23. PubMed ID: 27393006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical, physical, physiological, and dietary patterns of obese and sedentary adults with primary hypertension characterized by sex and cardiorespiratory fitness: EXERDIET-HTA study.
    Gorostegi-Anduaga I; Corres P; Jurio-Iriarte B; Martínez-Aguirre A; Pérez-Asenjo J; Aispuru GR; Arenaza L; Romaratezabala E; Arratibel-Imaz I; Mujika I; Francisco-Terreros S; Maldonado-Martín S
    Clin Exp Hypertens; 2018; 40(2):141-149. PubMed ID: 28783384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal increase in gamma-glutamyltransferase within the reference interval predicts metabolic syndrome in middle-aged Korean men.
    Ryu S; Chang Y; Woo HY; Yoo SH; Choi NK; Lee WY; Kim I; Song J
    Metabolism; 2010 May; 59(5):683-9. PubMed ID: 19922966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy of probiotics on the treatment of non-alcoholic fatty liver disease].
    Wang W; Shi LP; Shi L; Xu L
    Zhonghua Nei Ke Za Zhi; 2018 Feb; 57(2):101-106. PubMed ID: 29397594
    [No Abstract]   [Full Text] [Related]  

  • 30. Relationship between ultrasound features of nonalcoholic fatty liver disease and cardiometabolic risk factors in patients with newly diagnosed type 2 diabetes.
    Kosmalski M; Kasznicki J; Drzewoski J
    Pol Arch Med Wewn; 2013; 123(9):436-42. PubMed ID: 23792440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between decrease of erythrocyte count and progression of periodontal disease in a rural Japanese population.
    Yamamoto T; Tsuneishi M; Furuta M; Ekuni D; Morita M; Hirata Y
    J Periodontol; 2011 Jan; 82(1):106-13. PubMed ID: 20681815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholesteryl Ester Transfer Protein Variant (RS1800777) with Liver Histology in Non-Alcoholic Fatty Liver Disease Patients.
    Aller R; Izaola O; Primo D; de Luis D
    Ann Nutr Metab; 2018; 73(4):265-270. PubMed ID: 30293065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum carcinoembryonic antigen is associated with non-alcoholic fatty liver disease in healthy Korean non-smokers.
    Lee JY; Lee DC; Lee JW
    Clin Chem Lab Med; 2013 Jul; 51(7):1499-504. PubMed ID: 23392905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical correlates of persistently elevated liver enzymes in type 2 diabetic outpatients.
    Giandalia A; Romeo EL; Ruffo MC; Muscianisi M; Giorgianni L; Forte F; Cucinotta D; Russo GT
    Prim Care Diabetes; 2017 Jun; 11(3):226-232. PubMed ID: 28017576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Olive oil lessened fatty liver severity independent of cardiometabolic correction in patients with non-alcoholic fatty liver disease: A randomized clinical trial.
    Rezaei S; Akhlaghi M; Sasani MR; Barati Boldaji R
    Nutrition; 2019 Jan; 57():154-161. PubMed ID: 30170304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical parameters response to weight loss in patients with non-alcoholic steatohepatitis.
    Abd El-Kader SM; Al-Shreef FM; Al-Jiffri OH
    Afr Health Sci; 2016 Mar; 16(1):242-9. PubMed ID: 27358638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of uric acid levels with components of metabolic syndrome and non-alcoholic fatty liver disease in overweight or obese children and adolescents.
    Cardoso AS; Gonzaga NC; Medeiros CC; Carvalho DF
    J Pediatr (Rio J); 2013; 89(4):412-8. PubMed ID: 23791233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics.
    Omagari K; Kadokawa Y; Masuda J; Egawa I; Sawa T; Hazama H; Ohba K; Isomoto H; Mizuta Y; Hayashida K; Murase K; Kadota T; Murata I; Kohno S
    J Gastroenterol Hepatol; 2002 Oct; 17(10):1098-105. PubMed ID: 12201871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimation of gamma-glutamyl transferase as a suitable simple biomarker of the cardiovascular risk in children with non-alcoholic fatty liver disease.
    Bobrus-Chociej A; Flisiak-Jackiewicz M; Daniluk U; Wojtkowska M; Kłusek-Oksiuta M; Tarasów E; Lebensztejn D
    Acta Biochim Pol; 2018 Oct; 65(4):539-544. PubMed ID: 30380561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
    Alkassabany YM; Farghaly AG; El-Ghitany EM
    Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.